Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ixazomib in R/R Cutaneous and Peripheral T-cell Lymphomas
NCT02158975Phase 2Completed
- Sponsor
- University of Michigan Rogel Cancer Center
- Start
- Sep 2014
- Primary completion
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ixazomib in cutaneous T-cell lymphoma (CTCL), peripheral T-cell lymphoma (PTCL), sponsored by University of Michigan Rogel Cancer Center. Started Sep 2014; status: completed.
02
Drugs
ixazomib
03
Conditions
cutaneous T-cell lymphoma (CTCL)peripheral T-cell lymphoma (PTCL)
Beyond the preview
Go deeper on NCT02158975.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02158975.